Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial

作者：Shuya Li, Hongqiu Gu, Baoyu Feng, Hao Li, Xuechun Wang, Qiang Dong, Dongsheng Fan, Yun Xu, Suiqiang Zhu, Hongguo Dai, Yan Wei, Ziran Wang, Guozhi Lu, Yutong Ma, Zixiao Li, Yilong Wang, Yilong Wang, Meng Xia, Xingquan Zhao, Liping Liu, Yongjun Wang, Yongjun Wang · 发表于：The Lancet Neurology · 年份：2024 · DOI：10.1016/s1474-4422(24)00436-8 · 被引用次数：42 · 研究领域：Acute Ischemic Stroke Management、Protease and Inhibitor Mechanisms、Blood properties and coagulation